Hester Biosciences Q3 FY26 results: PAT up 140 percent, re-appoints CEO Rajiv Gandhi

Management Changes View source PDF Explain this filing

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.2%Reaction day

₹1440.00

prior close

₹1473.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.8%+2.3% vs market

Pharmaceuticals peers, median of 157sector+0.9%+3.2% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 3.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.9

15m

-0.3

30m

+1.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.2+1.8+2.3+0.9+3.2

Next day

+4.5+0.5+4.0+0.4+4.2

+4.9+4.3+0.6+2.4+2.5

+6.3+5.6+0.6+2.9+3.4

+4.6+4.6-0.0+2.2+2.4

+4.9+3.8+1.1+2.1+2.8

+7.6+7.5+0.1+4.3+3.3

15d

+8.9+3.8+5.1+1.2+7.7

+7.6-0.3+8.0-0.6+8.3

-12.5-9.6-2.9-10.1-2.4

+12.8+9.9+2.9+3.2+9.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Hester Biosciences Q3 FY26 standalone revenue grew 12 percent to INR 703.54 million and PAT jumped 140 percent to INR 106.69 million on 32 percent Poultry Healthcare growth. Animal Healthcare fell 38 percent due to delayed government orders. Consolidated revenue rose 22 percent but PAT dropped 18 percent. Board re-appointed founder-promoter Rajiv Gandhi as CEO and MD for 3 years from April 2026, pending shareholder approval.

Likely market impact

Strong Q3 profit growth from poultry, but weak animal healthcare and dip in consolidated PAT may keep sentiment mixed. CEO continuity is positive.